Breast Augmentation Filler Korea — Filler vs Implant vs Fat Transfer, Compared Honestly
Understand your real choices before you decide — injectable filler is not an approved breast augmentation option in Korea, while implants and fat transfer have established evidence, compared side by side in an informational 60-90 minute consultation from ₩19,000 (about $14) at RE:BERRY Hongdae, directly connected to Hongik University Station via AREX. See the options table and clinical evidence below.
Visit RE:BERRY across Seoul, Korea
Hongdae opens soon. Until then, explore our flagships — tap a clinic to view it.
ONE RE:BERRY BRAND · MFDS-REGISTERED DEVICES · MULTILINGUAL CARE AT EVERY LOCATION
Is breast augmentation filler a real option in Korea?
Breast augmentation filler Korea is not an approved option: RE:BERRY Hongdae explains from ₩19,000 (about $14) that no injectable filler is FDA-approved for the breast, copolyamide breast fillers were prohibited in Korea in 2016, and only implants and fat transfer have established evidence, so consult a board-certified plastic surgeon.
Breast augmentation filler Korea is a question best answered with regulatory honesty. Injectable ‘breast filler’ means placing a soft-tissue gel directly into the breast without surgery, but because the breast requires far larger volumes than the face, this carries a substantially higher risk profile. Copolyamide gels marketed as Aquafilling were prohibited for breast augmentation in Korea by the Korean Academic Society of Aesthetic and Reconstructive Breast Surgery in 2016, after reports of masses, deformity, infection, gel migration, asymmetry, and loss of the ability to breastfeed. Hyaluronic-acid breast injection has likewise been linked to serious complications, and no injectable filler is an FDA-approved or generally accepted breast augmentation method.
This RE:BERRY Hongdae page is informational: it compares the 3 real options — injectable filler, saline or silicone implants, and autologous fat grafting — so you can make an informed choice with a qualified, licensed specialist, and it does not assert that any injectable breast augmentation is offered. Over an informational 60-90 minute consultation, your assigned doctor explains where each option sits on approval, invasiveness, and screening safety, and how to verify a board-certified plastic surgeon before you decide.
Breast Augmentation Options Consultation at RE:BERRY Hongdae
Breast Augmentation Options: What to Discuss With a Specialist
How to Evaluate Breast Augmentation Options at RE:BERRY Hongdae
Understand the 3 Options (60-90 min informational visit)
Your breast augmentation filler Korea consultation is informational and lasts 60-90 minutes. Dr. Jae-Hong Kim lays out the 3 methods side by side — injectable filler, saline or silicone implants, and autologous fat grafting — and explains why only 2 of them, implants and fat transfer, have established evidence and regulatory approval for breast augmentation.
Review Approval and Safety Facts (15 min)
RE:BERRY Hongdae reviews the regulatory record with you: injectable silicone and injectable fillers are NOT FDA-approved for the breast, and copolyamide (Aquafilling-type) fillers were prohibited in Korea in 2016. Saline implants are FDA-approved from age 18 and silicone gel implants from age 22, with defined indications for augmentation and reconstruction.
Weigh Realistic Results and Screening Impact (15 min)
Each option is weighed for realistic size change and mammography impact: fat grafting typically gives a subtle 1 cup-size change with variable retention, implants give larger predictable volume, and large-volume filler risks nodules, migration, and interference with breast-cancer screening. RE:BERRY Hongdae frames these trade-offs so screening safety enters your decision.
Verify a Board-Certified Plastic Surgeon (10 min)
RE:BERRY Hongdae shows you how to verify a licensed specialist: check the KSPRS directory and HIRA registration, confirm the surgeon’s credentials, and ask about complication rates. Because this is an informational guide, your assigned doctor points you toward a qualified plastic surgeon rather than offering an unapproved injectable, with follow-up guidance in 8 languages.
Breast Augmentation Filler Korea: What an Honest Options Guide Covers
- Regulatory Honesty First: RE:BERRY Hongdae states plainly that breast augmentation filler Korea is not an approved method — no injectable is FDA-approved for the breast and copolyamide fillers were banned in 2016. This honesty protects you from marketing that presents ‘breast filler’ as a safe peer to implants.
- 3 Options Side by Side: The guide compares all 3 methods — injectable filler, implants, and fat transfer — on approval, invasiveness, realistic result, and screening safety. RE:BERRY Hongdae frames breast augmentation filler Korea within this spectrum so you understand where each sits rather than seeing only one marketed option.
- Screening Safety Included: RE:BERRY Hongdae compares how each option affects mammography and breast-cancer screening — a factor rarely shown across options. Large-volume filler can interfere with screening, while implants and fat grafting have defined imaging considerations, so long-term detection enters your decision from the start.
- Specialist Verification, Not a Sales Pitch: Because this is informational, RE:BERRY Hongdae teaches you to verify a board-certified plastic surgeon through the KSPRS directory and HIRA registration, and points you to a qualified specialist. There is no consultation fee, and guidance is provided in 8 languages with a 4-week WhatsApp follow-up.
| Timeline | What to Expect |
|---|---|
| All 3 options explained over 60-90 minutes, with approval status and screening impact reviewed side by side. | |
| You weigh realistic result and safety for each method; RE:BERRY Hongdae answers questions without pushing an unapproved injectable. | |
| You learn to confirm a board-certified plastic surgeon via KSPRS and HIRA before booking any surgical option. | |
| A 4-week WhatsApp follow-up supports international visitors after they return home, in 8 languages. |
Breast Augmentation Filler Korea vs Implants vs Fat Transfer
| Feature | Injectable Filler | Saline / Silicone Implant | Autologous Fat Transfer | Source |
|---|---|---|---|---|
| Approval for Breast Augmentation | Not FDA-approved; copolyamide banned in Korea 2016 | FDA-approved (saline 18+, silicone 22+) | Accepted autologous method with published evidence | FDA; MFDS; KSAPS 2016 |
| Invasiveness | Injection, but high-risk for the breast | Surgical device placement | Liposuction plus re-injection of own fat | Peer-reviewed literature |
| Realistic Size Change | Not a recommended method | Larger, predictable volume | Typically subtle, often near 1 cup size | Peer-reviewed literature |
| Main Complication Profile | Nodules, migration, infection, deformity | Capsular contracture, rupture, rippling | Fat necrosis, calcification, partial resorption | Peer-reviewed literature |
| Mammography / Screening Impact | Can interfere with screening | Defined imaging considerations | Calcifications may need imaging expertise | Peer-reviewed literature |
| Reversibility | Difficult once complications occur | Removable or exchangeable surgically | Not reversible; resorption over time | Peer-reviewed literature |
| Recommended Path | Avoid; not an approved option | Board-certified plastic surgeon | Board-certified plastic surgeon | RE:BERRY informational guidance |
Why This Matters
The central fact in breast augmentation filler Korea is regulatory: no injectable filler is FDA-approved for the breast, and copolyamide (Aquafilling) breast fillers were prohibited in Korea in 2016. RE:BERRY Hongdae leads with this so the comparison is honest, and only implants and fat transfer are presented as evidence-based options.
Specialist continuity matters for any surgical choice. According to KHIDI’s 2025 Medical Tourism Survey, 41.4% of Japanese patients ranked ‘same doctor throughout treatment’ as their number-one priority when choosing a Korean clinic. RE:BERRY Hongdae guides you toward a verified board-certified plastic surgeon for the approved options.
OECD 2023 data put the average Korean outpatient consultation at 4.3 minutes; RE:BERRY Hongdae spends an informational 60-90 minutes comparing options, because breast augmentation decisions involve long-term screening safety, not just size, and Korean clinics see higher medical-tourism volume than most Western markets.
Your Informational Consultation Physician at RE:BERRY Hongdae
Dr. Jae-Hong Kim
- Aesthetic Medicine Specialist, RE:BERRY Clinic Hongdae
- Korean Ministry of Health and Welfare Medical License No.138911
- Regular Member, Korean Dermatological Association (kda.or.kr)
- Patient-education and specialist-referral lead
Medically reviewed by Dr. Jae-Hong Kim, Aesthetic Medicine Specialist, RE:BERRY
SCIENTIFIC EVIDENCE Behind Breast Augmentation Options
The 6 peer-reviewed references below summarize the evidence and regulatory record across all 3 breast augmentation options, including the 2016 Korean position statement that prohibited copolyamide breast fillers, systematic data on autologous fat grafting, and safety literature on implants and injectable complications.
Why Injectable Breast Filler Is Not an Approved Option
The Korean Academic Society of Aesthetic and Reconstructive Breast Surgery issued a 2016 position statement prohibiting copolyamide (Aquafilling) breast fillers after reports of masses, deformity, infection, and migration, formally removing injectable copolyamide from accepted practice for breast augmentation in Korea.
Roh TS. Position Statement of Korean Academic Society of Aesthetic and Reconstructive Breast Surgery: Concerning the Use of Aquafilling for Breast Augmentation. Arch Aesthetic Plast Surg. 2016;22(1):45-46. doi:10.14730/aaps.2016.22.1.45
Hyaluronic-acid breast injection carries documented risk. A 2020 case report in Gland Surgery described serious complications after breast augmentation with hyaluronic acid, reinforcing that large-volume facial-type fillers are not a safe substitute for the 2 approved breast methods.
Trignano E, Baccari M, Pili N, et al. Complications after breast augmentation with hyaluronic acid: a case report. Gland Surg. 2020;9(6):2193-2197. doi:10.21037/gs-20-448
Autologous fat grafting has a substantial evidence base. A systematic review of cosmetic breast augmentation with fat grafting analyzed radiological safety, complications, volume retention, and satisfaction across many studies, reporting generally high satisfaction with variable, often partial fat retention over 12 months.
Groen JW, Negenborn VL, Twisk DJ, et al. Autologous Fat Grafting in Cosmetic Breast Augmentation: A Systematic Review on Radiological Safety, Complications, Volume Retention, and Patient/Surgeon Satisfaction. Aesthet Surg J. 2016;36(9):993-1007. doi:10.1093/asj/sjw105
Fat grafting to the breast was formally revisited for safety and efficacy in a foundational study of over 100 patients, establishing technique refinements and helping return autologous fat transfer to accepted practice with documented radiographic follow-up.
Coleman SR, Saboeiro AP. Fat grafting to the breast revisited: safety and efficacy. Plast Reconstr Surg. 2007;119(3):775-785. doi:10.1097/01.prs.0000252001.59162.c9
Implants remain the most predictable approved option. A 2014 review of the evolution of breast implants documented over 5 decades of device refinement, FDA-defined indications, and long-term safety data supporting saline and silicone gel implants for augmentation.
Maxwell GP, Gabriel A. The Evolution of Breast Implants. Plast Reconstr Surg. 2014;134(1 Suppl):12S-17S. doi:10.1097/PRS.0000000000000348
Long-term implant safety includes rare risks patients should know. A 2019 review of breast implant-associated anaplastic large cell lymphoma summarized proposed mechanisms and the small but real risk profile across textured-device populations, underscoring why an approved option should still be chosen with a specialist.
Rastogi P, Riordan E, Moon D, Deva AK. Theories of Etiopathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2019;143(3S):23S-29S. doi:10.1097/PRS.0000000000005566
Korean data further inform the fat-grafting option. A 2014 sonographic study of autologous fat grafting in the reconstructed breast in Korean patients quantified fat-absorption rate and safety over follow-up, adding local evidence to the approved autologous approach.
Kim HY, Jung BK, Lew DH, Lee DW. Autologous fat graft in the reconstructed breast: fat absorption rate and safety based on sonographic identification. Arch Plast Surg (J Korean Soc Plast Reconstr Surg). 2014;41(6):740-747. doi:10.5999/aps.2014.41.6.740
These 7 references support the RE:BERRY Hongdae informational protocol: honest comparison of the 3 options, clear approval status, screening-safety weighting, and referral to a licensed plastic surgeon verified via KSPRS and HIRA. This information is for educational purposes only and is not medical advice.
Only Authentic, Brand-Certified Equipment
Every device at RE:BERRY is MFDS-certified and manufacturer-verified. We never use counterfeit or grey-market equipment.
Brand-Authenticated Equipment & Training
Our doctors are certified by Korea’s top dermatological societies
Numbers That Tell Our Story
Real procedures performed.
Breast Augmentation Filler Korea — Frequently Asked Questions
Regulatory facts, options comparison, and specialist-verification answers for breast augmentation filler Korea, updated for 2026. Informational only.
Is filler a legitimate breast augmentation option in Korea or not?
RE:BERRY Hongdae states clearly that breast augmentation filler Korea is not an approved option: no injectable filler is FDA-approved for the breast, and copolyamide (Aquafilling) fillers were prohibited in Korea in 2016. Only 2 methods, implants and fat transfer, have established evidence, so consult a board-certified plastic surgeon.
Why is injectable filler not an approved breast augmentation method here?
RE:BERRY Hongdae explains that copolyamide breast fillers were banned in Korea in 2016 after reports of masses, deformity, infection, and migration. The breast needs far larger volumes than the face, so large-volume injectables carry a substantially higher risk than the 2 approved surgical options.
What is the difference between breast filler, implants, and fat transfer?
RE:BERRY Hongdae compares the 3 methods: injectable filler is unapproved and high-risk, implants are FDA-approved devices giving larger predictable volume, and fat transfer uses your own tissue for a subtle change. Korean clinics see higher medical-tourism volume than most Western markets, so options are explained thoroughly.
| Method | Approval | Result |
|---|---|---|
| Filler | Not approved | Avoid |
| Implant | FDA-approved | Larger volume |
| Fat transfer | Accepted | Subtle change |
Which breast augmentation methods are FDA-approved and which are not?
RE:BERRY Hongdae confirms that saline implants are FDA-approved from age 18 and silicone gel implants from age 22, while injectable silicone and fillers are NOT FDA-approved for the breast. Fat transfer is accepted with evidence; for approved facial care instead, see the Ultherapy Prime page.
Are silicone or saline breast implants safe, and for whom in Korea?
RE:BERRY Hongdae explains that saline implants are FDA-approved from age 18 and silicone from age 22, placed by a board-certified plastic surgeon. Korean clinics see higher medical-tourism volume than most Western markets; risks include capsular contracture and a small BIA-ALCL risk, so RE:BERRY reviews all 3 options first.
How safe is fat grafting compared with implants for the breast?
RE:BERRY Hongdae summarizes that autologous fat grafting uses your own fat for a subtle 1 cup-size change, with variable retention and high satisfaction in systematic reviews from Korea and abroad. Implants give larger volume; both carry less regulatory risk than injectable breast augmentation filler Korea, which is not approved.
How much size increase can each breast augmentation method give?
RE:BERRY Hongdae notes that fat grafting typically gives a subtle change of about 1 cup size with partial resorption, while implants offer larger, more predictable volume chosen by the surgeon. Injectable filler is not a recommended method, so the 2 realistic options are compared during your 60-90 minute informational consultation.
Can breast augmentation material interfere with cancer screening?
RE:BERRY Hongdae warns that large-volume injectable filler can interfere with mammography, 1 key reason it is not approved. Implants have defined imaging considerations and fat grafting may cause calcifications needing expert imaging, so RE:BERRY weighs screening safety across all 3 options for you.
Is breast augmentation cheaper in Korea than in the US or Japan?
RE:BERRY Hongdae keeps the 1 informational consultation transparently priced and published before you book, rather than quoting other countries. Korean clinics see higher medical-tourism volume than most Western markets, and surgical options are priced separately by the board-certified plastic surgeon you are referred to.
Which option gives the most natural, subtle result in Seoul?
RE:BERRY Hongdae explains that autologous fat transfer is usually chosen for a natural, subtle change of about 1 cup size using your own tissue, while implants suit larger volume. Injectable filler is not recommended; see the botox page for approved facial treatments we offer.
How do I verify a board-certified plastic surgeon in Korea?
RE:BERRY Hongdae shows you 2 checks to verify a specialist — the KSPRS directory and HIRA registration — confirming credentials before any surgical booking. Korean clinics see higher medical-tourism volume than most Western markets; RE:BERRY provides this guidance in 8 languages and refers you to a qualified plastic surgeon.
What should I ask during a breast augmentation consultation in Seoul?
RE:BERRY Hongdae recommends asking 3 things: which method is approved, what the complication and screening impact is, and whether the surgeon is board-certified. RE:BERRY answers these in an informational 60-90 minute session; see the Ultherapy Prime page for non-surgical options we provide.
Does RE:BERRY Hongdae offer injectable breast augmentation filler?
RE:BERRY Hongdae does not offer injectable breast augmentation filler, because it is not an approved method and copolyamide gels were banned in Korea in 2016. This 1 page is informational; for the approved facial treatments RE:BERRY does provide, see the Thermage FLX page.
Who should avoid injectable breast fillers according to the guide?
RE:BERRY Hongdae advises all patients to avoid the 1 unapproved route of injectable breast fillers, especially those pregnant or breastfeeding, with active infection, or with breast-disease risk factors where clear screening matters. No injectable breast augmentation filler Korea product is approved or generally accepted.
How many days should I stay in Seoul for an options consultation?
RE:BERRY Hongdae completes the informational options consultation within 1-2 hours, so half a day in Seoul covers it. The clinic connects to Hongik University Station via AREX; see the Sofwave page for non-surgical lifting, and a 4-week WhatsApp follow-up supports you after you fly home.
Book an Informational Breast Augmentation Options Consultation at RE:BERRY Hongdae
Compare breast augmentation filler Korea honestly against implants and fat transfer from ₩19,000 (about $14) at RE:BERRY Hongdae, directly connected to Hongik University Station via AREX. Dr. Jae-Hong Kim explains approval facts and refers you to a board-certified plastic surgeon. This information is educational and not medical advice; RE:BERRY does not offer injectable breast augmentation. Consult a licensed physician for individual guidance.
Related Treatments
Why Tens of Thousands of Foreign Patients Are Choosing This Seoul Skin Clinic — Business Wire, 2026-04-13
Book Your Personalized Consultation
Share your details and our multilingual team will contact you within 24 hours through your preferred messenger.
- ✓ Free online skin consultation with a doctor
- ✓ Personalized treatment plan & pricing
- ✓ Airport pickup coordination available
- ✓ 8-language support (EN/JP/CN/TW/TH/ES/MN/AR)
- ✓ Response within 24 hours via your preferred messenger
How to Find RE:BERRY Hongdae
Directly connected to Hongik University Station (Line 2, AREX, Gyeongui–Jungang Line) via the AREX underground passage. 3F & B2, 140 Yanghwa-ro, Mapo-gu, Seoul.
RE:BERRY Clinic Hongdae Opening Soon
3F & B2, 140 Yanghwa-ro, Mapo-gu, Seoul 04039
서울시 마포구 양화로 140, 3층·지하2층 (동교동 162-15)
Open now at: Gangnam · Myeongdong · Incheon Airport